Ertapenem sodium and Encephalopathy - a phase IV clinical study of FDA data

Summary:

Encephalopathy is reported as a side effect among people who take Ertapenem sodium (ertapenem sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Meropenem, and have Fever.

The phase IV clinical study analyzes which people have Encephalopathy when taking Ertapenem sodium. It is created by eHealthMe based on reports of 1,521 people who have side effects when taking Ertapenem sodium from the FDA, and is updated regularly.

What is Ertapenem sodium?

Ertapenem sodium has active ingredients of ertapenem sodium. eHealthMe is studying from 1,524 Ertapenem sodium users. Check the latest studies of Ertapenem sodium.

What is Encephalopathy?

Encephalopathy (functioning of the brain is affected by some agent or condition) is found to be associated with 1,465 drugs and 1,602 conditions by eHealthMe. Check the latest studies of Encephalopathy.

On Jul, 13, 2026

1,521 people reported to have side effects when taking Ertapenem sodium.
Among them, 34 people (2.24%) have Encephalopathy.

Could Ertapenem sodium cause Encephalopathy?

Among these 34 people:

How long have people been on Ertapenem sodium when they have Encephalopathy? *

What is the gender of people who have Encephalopathy when taking Ertapenem sodium? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Encephalopathy when taking Ertapenem sodium? *

What are other drugs people take besides Ertapenem sodium? *

Meropenem: 3 people, 8.82%
Quetiapine Fumarate: 2 people, 5.88%
Sodium Chloride: 1 person, 2.94%
Sertraline Hydrochloride: 1 person, 2.94%
Risperidone: 1 person, 2.94%
Plavix: 1 person, 2.94%
Pantoprazole: 1 person, 2.94%
Lantus: 1 person, 2.94%
Haloperidol: 1 person, 2.94%
Clopidogrel: 1 person, 2.94%

What are other side effects people have besides Encephalopathy? *

Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 4 people, 11.76%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 5.88%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 2.94%
Leukocytosis (increased white blood cells): 1 person, 2.94%
Insomnia (sleeplessness): 1 person, 2.94%
Infection: 1 person, 2.94%
Hepatitis (inflammation of the liver): 1 person, 2.94%
Hepatic Failure (liver failure): 1 person, 2.94%
Hallucination, Visual (seeing things that aren't there): 1 person, 2.94%
Gait Disturbance: 1 person, 2.94%

What are the existing conditions these people have? *

Urinary Tract Infection: 9 people, 26.47%
Fever: 9 people, 26.47%
Psychomotor Hyperactivity (feelings of extreme restlessness): 6 people, 17.65%
Agitation (state of anxiety or nervous excitement): 5 people, 14.71%
Infected Lymphocele (infected abnormal collection of lymphatic fluid): 3 people, 8.82%
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 2 people, 5.88%
Bacteraemia (presence of bacteria in the blood): 1 person, 2.94%
Aptyalism (deficiency or absence of saliva): 1 person, 2.94%
Confusional State: 1 person, 2.94%
Abscess (pus): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Ertapenem sodium and have Encephalopathy?

- Check whether Encephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ertapenem sodium:

Ertapenem sodium (1,524 reports)

Encephalopathy treatments and more:

Encephalopathy (27,832 reports)

Browse all side effects of Ertapenem sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Encephalopathy:

Encephalopathy (1,465 drugs)

Browse all the conditions that are associated with Encephalopathy:

Encephalopathy (1,602 conditions)

Related publications that referenced our studies

Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .
Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on ertapenem sodium (the active ingredients of Ertapenem sodium) and Ertapenem sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.